for specific and saturable uptake of LDL-cholesterol and skin fibroblasts as well as hepatocytes express [3, 4] . Glomerular epithelial cells also take up LDL via VLDL receptor mRNA, indicating that they exhibit the apoB,E receptor [5, 6 ] , even though they are barely VLDL receptors. VLDL uptake in glomerular epitheexposed to LDL in vivo [7] . The LDL receptor exhibits lial cells, mesangial cells and skin fibroblasts occurred interaction with apoB-or apoE-containing lipoprowith a lower specificity than in HepG2 cells (−25%).
Methods. Uptake kinetics of 125I-labelled very-lowAccumulation of lipoproteins within the glomerulus density lipoproteins ( VLDL) and low-density lipoproand preferentially in the mesangium has been considteins (LDL) in human glomerular epithelial and mesered to be a mediator of glomerular injury [1, 2] . The angial cells were compared to lipid uptake in cells with mechanisms leading to lipoprotein accumulation in established receptor status, i.e. human skin fibroblasts humans are not fully understood. Several studies conand HepG2 cells.
firmed that human mesangial cells possess receptors Results. Glomerular epithelial cells, mesangial cells, for specific and saturable uptake of LDL-cholesterol and skin fibroblasts as well as hepatocytes express [3, 4] . Glomerular epithelial cells also take up LDL via VLDL receptor mRNA, indicating that they exhibit the apoB,E receptor [5, 6 ] , even though they are barely VLDL receptors. VLDL uptake in glomerular epitheexposed to LDL in vivo [7] . The LDL receptor exhibits lial cells, mesangial cells and skin fibroblasts occurred interaction with apoB-or apoE-containing lipoprowith a lower specificity than in HepG2 cells (−25%).
teins. Among its ligands, apoE is bound with higher No differences were found for the specificity of LDL affinity than apoB, which leads to enhanced affinity uptake. VLDL uptake in HepG2 cells was inhibited for apoB-and apoE-containing VLDL compared with more effectively with VLDL than with LDL. In skin only apoB-containing LDL [8, 9] . fibroblasts, glomerular epithelial and mesangial cells,
Recently we compared the uptake of LDL and VLDL and LDL were equally effective inhibitors of intermediate density lipoprotein (IDL) by glomerular VLDL uptake. The degradation-uptake ratio of VLDL epithelial cells and human skin fibroblasts and demonin glomerular cells was elevated 50% compared to strated an enhanced uptake of apoE-rich nephrotic HepG2 cells, suggesting highly efficient intracellular IDL by glomerular epithelial cells but not by lipoprotein turnover in these cells.
fibroblasts. We hypothesized, that glomerular epithelial Conclusion. We conclude that glomerular epithelial cells could possess an additional receptor for the uptake and mesangial cells as well as skin fibroblasts and of apoE-rich lipoproteins [4] . The VLDL receptor, a HepG2 exhibit VLDL receptors additionally to their member of the family of genes that is related to the LDL receptors, even though the regulation of the LDL receptor gene might be such a candidate. The VLDL receptor in HepG2 cells seems to differ from VLDL receptor consists of five functional domaines the regulation in glomerular epithelial and mesangial that resemble the LDL receptor but it only binds the cells. The high degradation-uptake-ratio in these renal apoE-containing lipoproteins VLDL, IDL and bcells suggests the presence of an effective clearance VLDL [10] and does not bind apoB-containing LDL. Despite their structural similarity, the tissue expression of these two lipoprotein receptors is completely differ-studied showed the morphological and immunological chari.e. heart, skeletal muscle and adipose tissue [10]. In acteristics described by others for glomerular epithelial cells contrast to the LDL receptor, only trace amounts are [17, 18] . Rabbit anti-mouse IgG, pig anti-rabbit IgG, peroxidfound in the liver. 
Cell cultures
Human glomerular epithelial cells were isolated from patients Lipid and apolipoprotein analysis undergoing tumour nephrectomy. Glomeruli were prepared using a sieving technique as previously described [13] . Cells For determination of lipoprotein composition, cholesterol, from the fifth to tenth subculture were used in all experiments. triglycerides and phospholipids were measured enzymatically using a Wako R-30 analyser ( Wako, Neuss, Germany Braunschweig, Germany) and 30 ml iodine-monochloride logy with polyhedral shape and a cobblestone-like appearance. All cell lines showed the same morphological and were added per milligram lipoprotein-protein in 100 ml glycine buffer (1M, pH 10). Radiolabelled lipoproteins were immunological characteristics as described by Kreisberg and Karnowski [16 ] . Cells were homogenously positive for sterilized by passage through a 0.45-mm filter and used within 2 weeks. vimentin and negative for cytokeratin. Therefore, the cells
Radioiodination of lipoproteins Glomerular epithelial cells
dNTP, 10 mM random hexanucleotide primer, 10 mM
Preparation of LDS
dithithreitol, RNase inhibitor (10 U/100 ng total RNA) an MML1V reverse transcriptase (50 U/100 ng total RNA). The Human lipoprotein deficient serum (LDS) was prepared by total RV volume (10 ml ) was incubated at 37°C for 1 h ultracentrifugation (150 000 g for 48 h at 10°C ), adjusting followed by denaturation at 95°C for 5 min. To exclude the plasma to d=1.250 kg/l by addition of solid KBr. The amplification of contaminating DNA, control experiments resulting LDS was dialysed against 154 mmol/l NaCl, were carried out in the absence of reverse transcriptase. 250 mmol/l EDTA·Na 2 , 5 mmol/l HEPES, pH 7.4, heatinactivated at 54°C for 1 h and sterilized by passage through a 0.45-mm filter. Finally the protein content was adjusted PCR amplification to 40 g/l.
Aliquots of 10 ml reverse transcription samples were added to 35 ml of PCR master mix (16 mM Tris-HCl, pH 8.3,
Binding, internalization, and degradation of lipoproteins
40 mM KCl, 0.4 mM MgCl 2 ). The mixture was overlaid with mineral oil and heated at 94°C for 1 min. The samples were To induce maximal LDL receptor activity, cells were preinkept at 80°C until 5 ml start mix, containing 2.5 U Taq DNA cubated in medium containing 10% LDS. After 48 h, LDSpolymerase and 20 pmol sense and antisense primer respectcontaining medium was replaced and 125I-labelled LDL or ively, was added. The cycle profile included denaturation at VLDL with or without a 25-fold excess of unlabelled lipopro-94°C for 1 min, annealing at 60°C for 1 min and elongation teins was added. The cultures were incubated for 5 h at 37°C.
at 72°C for 1 min. To examine the cycle dependency of the The medium was removed and the cells were placed on ice.
amplification process, 24-36 cycles were performed. We The culture dishes were then washed five times with a cold could demonstrate a linear relationship between cycles 26 buffer containing 154 mmol/l NaCl, 50 mmol/l TRIS and 28. Primers were chosen from sequences of the human (pH 7.4) and 2 mg/ml bovine serum albumin (fatty acid VLDL receptor as previously published [26 ] : CTGACfree). Binding, internalization, and degradation were meas-TGCGAAGATGGTTCA, antisense: TGCATTCTCCACTTured by standard methods [4, 25] . The heparin-releasable CTGCAC. The size of the amplification product was 711 bp. radioactivity represented the binding at 37°C. After the release of cell surface-bound radioactivity by heparin, monolayers were dissolved in 1 ml of 0.1 N NaOH and radioactiv-PCR product detection ity and protein were determined. The radioactivity in the pellet was considered as a measure of internalization. Non-The amplification products of 10 ml of each PCR were iodide trichloroacetic acid-soluble radioactivity in the culture fractionated by electrophoresis on 1.5% agarose gel conmedium served as a measure of lipoprotein degradation. taining ethidium bromide (0.5 mg/ml ). Photographs of the Non-specific binding, internalization, and degradation were gels were taken under ultra-violet irradiation with polaroid estimated in the presence of a 25-fold excess of unlabelled film. ligand. All experiments were performed in triplicate.
Statistics Inhibition of receptor-mediated lipoprotein uptake
Maximum capacities and affinities were obtained by To assess the capability of VLDL and LDL to displace Scatchard plot analysis [27] . Specificity was determined by labelled lipoproteins from receptor binding, displacement withdrawal of unspecific binding measured after preincubaexperiments were carried out. The experimental procedure tion with 25-fold amount of unlabelled lipoproteins. The was analogous to the assay for lipoprotein uptake described lipoprotein concentration, by which 50% VLDL or LDL above. After preincubation with 10% LDS containing were displaced was determined by logit-plot method [28, 29] . medium for 48 h, cell cultures were incubated with increasing To calculate the relationship between degradation and uptake concentrations of unlabelled VLDL or LDL respectively. of lipoproteins, degradation during 5 h of incubation was Then 2 mg 125I-labelled VLDL or 10 mg 125I-labelled LDL divided through uptake (which represents the sum of bound were added to every well, and after incubation at 37°C for and internalized lipoproteins). 5 h, analysis followed as described above.
Results are given as means±standard error of the mean (SEM ). Analysis of significance was performed using paired or unpaired Student's t test as appropriate. internalized, and degraded LDL in a concentrationdependent, receptor-specific, and saturable manner Reverse transcription ( Figure 1 In order to compare the relationship between degradation and uptake of LDL, a ratio between those two parameters was calculated ( Table 2 ). This ratio in glomerular epithelial cells and mesangial cells was nearly twice as high as in fibroblasts and HepG2.
Gene expression of VLDL

Cellular uptake of VLDL
VLDL was bound, internalized, and degraded in a concentration-dependent and saturable manner by all cell lines (Figure 2 ). Maximum capacities were highest (Table 1) . Average K d for binding, mean±SEM of four independent experiments for each cell type. All internalization and degradation of VLDL by measurements were carried out in triplicate. For symbols without fibroblasts and mesangial cells was 10 mg/ml ( Table 1) , error bars the SEM was less than the symbol size. while glomerular epithelial cells and HepG2 showed Table 1 . Concentration-dependent uptake of 125I-labelled LDL and VLDL by skin fibroblasts (Fib), HepG2, mesangial cells (MC ), and glomerular epithelial cells (GEC )
HepG2
Fib MC GEC
(mg/ml ) (ng/mg) (mg/ml ) (ng/mg) (mg/ml ) (ng/mg) (mg/ml ) Binding  651  36  566  22  208  25  137  22  Internalization  3165  32  1999  20  992  21  180  21  Degradation  4916  19  6470  18  3497  15  1128  16  VLDL  Binding  114  9  86  10  40  20  33  8  Internalization  390  5  358  13  207  11  62  9  Degradation  752  5  979  9  387  10  221  7 higher affinity ( K d =8 mg/ml and K d =7 mg/ml respect-calculated lipoprotein concentrations which displaced 50% of 125I-labelled VLDL. While this displacement ively). In contrast to the low-affinity uptake of LDL by HepG2, VLDL uptake occurred with higher affinity was achieved by about the same amount of LDL for all cells (between 117 mg/ml for glomerular epithelial in HepG2 than in mesangial cells and fibroblasts. The high affinity of HepG2 to the VLDL particle corre-cells and 161 mg/ml for fibroblasts), significant differences were seen in inhibition with VLDL: 50% displacesponded with a specificity for binding, internalization and degradation of VLDL by HepG2 of 81% on ment of 125I-labelled VLDL was achieved by 30 mg/ml VLDL in fibroblasts, 24 mg/ml in glomerular epithelial average. Fibroblasts, mesangial cells and glomerular epithelial cells displayed only a specificity of 63-66%. cells and 22 mg/ml in mesangial cells but only 4 mg/ml in HepG2 ( Table 3 ). The ratio of VLDL degradation per VLDL uptake was twice as high for glomerular epithelial cells and fibroblasts compared with HepG2 and mesangial cells Gene expression of VLDL receptor mRNA ( Table 2) , indicating more efficient VLDL catabolism Glomerular epithelial cells, mesangial cells and skin in glomerular epithelial cells and fibroblasts. To analyse fibroblasts as well as hepatocytes exhibited sharp diswhether cells preferably degrade LDL or VLDL, tinct signals in detection of VLDL receptor mRNA degradation-uptake ratios for these lipoproteins were ( Figure 5 ). Compared to the other cells, the signal compared: No significant differences were seen in obtained from HepG2 cells was lower. Therefore fibroblasts and HepG2, while degradation-uptake ratio VLDL receptor mRNA was expressed indicating the in glomerular epithelial and mesangial cells was higher presence of the VLDL receptor in these four cell types. for LDL than for VLDL.
LDL
Maximum capacities for VLDL were compared with those of LDL (100%). Relative maximum capacity for
Discussion
VLDL was about 16% in fibroblasts, HepG2 and mesangial cells. Glomerular epithelial cells displayed the highest VLDL capacity (25%). In conclusion, the It is generally accepted that lipoprotein uptake by glomerular cells is linked to the progression of glomercharacteristics of VLDL uptake by glomerular epithelial cells were high affinity, relative high capacity and ular disease [30, 31] , whereas the mechanisms of lipid deposition in the glomerulus are not completely underhigh degradation efficiency leading to the impression of preferential VLDL catabolism by glomerular epithe-stood. So far it has been documented that lipoprotein uptake by mesangial and glomerular epithelial cells is lial cells.
receptor-mediated and concentration dependent [5, 6 ] . The present study sought to further characterize the Inhibition of LDL uptake by LDL and VLDL mechanisms of lipid uptake by glomerular cells. First, we attempted to clarify the question of whether glomerCell cultures were incubated with labelled LDL or VLDL to analyse their capability to displace increasing ular epithelial or mesangial cells possess specific VLDL receptors besides the well-established LDL receptors. concentrations of unlabelled lipoproteins from their receptors. Inhibition of LDL uptake was concentraUsing a homologous system of human lipoproteins and cells, we confirmed that glomerular epithelial and tion dependent and saturable. A 50% inhibition was achieved with a VLDL concentration of 50 mg/ml, mesangial cells possess the capability of receptormediated lipoprotein uptake. LDL uptake, which regardless of the cell type ( Figures 3 A-D) . When LDL uptake was inhibited with unlabelled LDL nearly occurs via the LDL receptor in all cell types, was of similar specificity in HepG2, fibroblasts, mesangial and 90% inhibition was achieved with 250 mg protein/ml of unlabelled LDL. There were no cell specific differences glomerular epithelial cells. VLDL uptake, in contrast, was much higher in HepG2 than in fibroblasts and for the inhibition of LDL uptake with either LDL or VLDL. The logit-plot method showed that a 50% renal cells. HepG2 also revealed similar specificity for VLDL and LDL whereas the affinity for VLDL was displacement of receptor bound 125I-labelled LDL was achieved with approximately 18 mg protein/ml LDL or lower in fibroblasts and renal cells. These findings are consistent with the presence of VLDL receptors on 25 mg/ml VLDL ( Table 3) . These values did not differ between cell lines. these four cells determined by detection of VLDL receptor mRNA. They furthermore suggest that expression and regulation of the VLDL receptor varies Inhibition of VLDL uptake by LDL and VLDL among the cells. Jingami and Yamamoto [10] recently demonstrated that induction and regulation of the Furthermore the inhibitory effects of unlabelled LDL and VLDL on uptake of 125I-labelled VLDL were VLDL receptor is tissue specific. Especially the inhibition of receptor expression by cholesterol seems to be compared. In HepG2 cells, maximal inhibition of VLDL uptake by LDL was 60%, while inhibition of dependent on the physiological function of the cells and their role in the lipid metabolism [32] . This VLDL uptake by VLDL was 85%. In contrast, there were no significant differences between inhibition of suggestion was supported by the displacement experiments: in fibroblasts and renal cells, inhibition VLDL uptake by unlabelled VLDL and LDL for fibroblasts, glomerular epithelial or mesangial cells of 125I-labelled VLDL uptake with unlabelled VLDL was equally as effective as that with unlabelled LDL. (Figure 4 A-D) . These results were underlined by the hindrance. These effects are expected to increase if the distance between two receptors decreases, as it is found in the higher density of receptors on the surface of HepG2. For the same reason, the sterical disturbance In HepG2, which are known to possess VLDL recepof the lipoprotein-binding is enhanced with increase in tors [11] , unlabelled VLDL showed markedly higher the particle size. Therefore, receptor density is even displacement of 125I-labelled VLDL uptake. more important in the binding of VLDL, which Differences between the LDL receptor on fibroblasts exhibits more than twice the diameter of LDL [36 ] . and on HepG2 have been described before [33] . Temperature-dependent lipoprotein binding of the hep-Accordingly, glomerular epithelial cells with the lowest LDL receptor density showed elevated VLDL uptake compared to their LDL uptake, though their maximum capacity for VLDL was markedly lower than in HepG2. This leads to the impression of a preferential uptake of apoE-rich lipoproteins by glomerular epithelial cells, as was described before [4] . The enhanced uptake of apoE-containing lipoproteins in glomerular epithelial cells compared to fibroblasts or mesangial cells seems to be due to the tissue specific characteristics of the VLDL and LDL receptor.
Since HepG2 cells internalized a relatively larger amount of lipoproteins, the degradation-uptake ratio of VLDL and LDL in those cells was accordingly reduced. This has been attributed to a delayed release of lipoproteins from endosomes [37] . In contrast, renal cells revealed the highest efficiency for LDL catabolism which-in combination with low affinity and low maximal capacity-seems to prevent renal cells from especially for glomerular epithelial cells, whose recep-
